Escherichia coli is the most common cause of bacterial prostatitis. Findings from a small study suggest it could be an effective, safe, and attractive alternative to fluoroquinolones, bacterial ...
Meitheal Pharmaceuticals said it has acquired the North American rights to a novel antibiotic for treating complicated urinary tract infections. The company said yesterday it's buying Contepo ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback